Combining unbiased AI with the entire historical Compendium of drug development will forever changes the pharmaceutical industry.
True Artificial Intelligence: Unbiased AI/ML creates unbiased predictions minimizing false positives and false negatives. By doing the hardest thing first, Repurpose. AI reduces the amount of wet chemistry validation required to discover a novel drug-target combination by multiple orders of magnitude as compared to other "AI" approaches to Drug Discovery.
The Data: Repurpose.AI's AI/ML Digital Chemistry Platform stands on the shoulders of decades of research led by the world's most talented scientists, trillions of dollars of taxpayer, stockholder and privately funded pharmaceutical investments and millions of brave clinical trial patients. Rather than recreate the wheel, or be beholden to outdated modes of thinking, we honor their toil, investments and sacrifice by using that data to fuel our Drug Discovery Engine.
Total Funding: N/A
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2019